| 1984 |
Retinal atrophy, progressive, TTC8-related |
1 |
Human gene
|
34.0 |
| 1985 |
Dwarfism, GON4L-related |
1 |
Animal disease only
|
|
| 1986 |
Severe combined immunodeficiency disease, autosomal, T cell-negative, B cell-negative, NK cell-positive, with sensitivity to ionizing radiation |
1 |
Target evidence
|
57.5 |
| 1987 |
Tail, short and kinked (Japanese bobtail) |
1 |
Target evidence
|
50.7 |
| 1988 |
Copper toxicosis, COMMD1-related |
1 |
Animal disease only
|
|
| 1989 |
Onychomadesis, symmetrical |
1 |
Human disease
|
9.0 |
| 1990 |
Cancer, TP53-related |
5 |
Drug
|
84.9 |
| 1991 |
Stillbirth |
1 |
Human gene
|
26.5 |
| 1993 |
Ichthyosis, generic |
4 |
Human disease
|
15.0 |
| 1994 |
Rex coat, plaice type |
1 |
Animal disease only
|
|
| 1996 |
Achondroplasia-1 |
1 |
Animal disease only
|
|
| 1997 |
Achondroplasia-2 |
1 |
Animal disease only
|
|
| 1998 |
Dwarfism, Dahlem |
1 |
Animal disease only
|
|
| 2002 |
Furless |
1 |
Animal disease only
|
|
| 2003 |
Pelt-loss |
1 |
Animal disease only
|
|
| 2004 |
Chondrodystrophy with femoral luxation |
1 |
Animal disease only
|
|
| 2007 |
Agenesis, renal |
4 |
Human disease
|
15.0 |
| 2011 |
B-cell deficiency |
1 |
Human disease
|
7.5 |
| 2012 |
Glioma, predisposition to |
3 |
Human disease
|
9.0 |
| 2013 |
Skeletal atavism |
1 |
Human disease
|
9.0 |
| 2014 |
Enteritis, necrotic, susceptibility/resistance to |
1 |
Animal disease only
|
|
| 2015 |
Dental hypomineralization |
1 |
Target evidence
|
58.3 |
| 2016 |
Van den Ende-Gupta syndrome |
1 |
Target evidence
|
61.1 |
| 2017 |
Glaucoma 3, primary congenital |
1 |
Human disease
|
14.0 |
| 2018 |
Stiff skin syndrome |
1 |
Human disease
|
9.0 |
| 2020 |
Ligneous membranitis |
1 |
Drug
|
69.5 |
| 2022 |
Arthrogryposis multiplex congenita, CHRNB1-related |
1 |
Human gene
|
34.0 |
| 2023 |
Cystinuria, type B |
1 |
Target evidence
|
83.5 |
| 2025 |
Erratic |
1 |
Animal disease only
|
|
| 2026 |
Wobbly |
1 |
Animal disease only
|
|
| 2028 |
Myeloperoxidase deficiency |
1 |
Drug
|
63.4 |
| 2029 |
Retinitis pigmentosa 1 |
1 |
Target evidence
|
59.7 |
| 2030 |
Cataract and non-ketotic hyperglycinaemia |
1 |
Human disease
|
9.0 |
| 2031 |
Lundehund syndrome |
1 |
Animal disease only
|
|
| 2032 |
Neuropathy, sensory, RETREG1-related |
1 |
Human gene
|
34.0 |
| 2034 |
Cerebellar cortical degeneration, SNX14-related |
1 |
Target evidence
|
57.0 |
| 2035 |
Abortion (embryonic lethality), OBFC1-related |
1 |
Human gene
|
29.0 |
| 2036 |
Abortion (embryonic lethality), TTF1-related |
1 |
Animal disease only
|
|
| 2037 |
Abortion (embryonic lethality), RABGGTB-related |
1 |
Animal disease only
|
|
| 2038 |
Abortion (embryonic lethality), RNF20-related |
1 |
Animal disease only
|
|
| 2039 |
Abortion (embryonic lethality), MYH6-related |
1 |
Animal disease only
|
|
| 2040 |
Abortion (embryonic lethality), SNAPC4-related |
1 |
Animal disease only
|
|
| 2041 |
Abortion (embryonic lethality), RPIA-related |
1 |
Target evidence
|
55.4 |
| 2042 |
Abortion (embryonic lethality), EXOSC4-related |
1 |
Animal disease only
|
|
| 2043 |
Abortion (embryonic lethality), MED22-related |
1 |
Animal disease only
|
|
| 2044 |
Ataxia telangiectasia, ATM-related |
2 |
Human disease
|
35.0 |
| 2045 |
Bardet-Biedl syndrome 4 |
1 |
Human gene
|
34.0 |
| 2046 |
Glaucoma, primary open angle |
1 |
Animal disease only
|
|
| 2047 |
XX sex reversal, SRY-related |
3 |
Human disease
|
20.0 |
| 2048 |
Hypocalcaemia, predisposition to |
1 |
Human disease
|
29.0 |
